WebFinancial calendar Dates for our financial publications and our Ordinary General Meeting. Our next conference call: April 20, 2024 We conduct conference calls for analysts and investors on the day of each quarterly publication. We will make the dial-in details available several days ahead of the call. Further information WebJan 8, 2016 · Novartis Q4/FY 2015 Results January 27, 2016 - 14:00 CET. We are pleased to invite you to a conference call and live audio webcast for the Novartis Q4/FY 2015 Presentation on Wednesday, January 27 ...
Financial calendar Swiss Re
WebMar 6, 2024 · An icon in the shape of a calendar. Economic Earnings. Search markets. A magnifying glass. ... [email protected] : Novartis Investor Relations : Central investor relations line: +41 61 324 ... WebSep 22, 2024 · E-mail: [email protected]. Central . North America . Samir Shah +41 61 324 7944. Sloan Simpson +1 862 345 4440. Nicole Zinsli-Somm +41 61 324 3809. Alina Levchuk +1 862 778 3372. how to report fisher\u0027s exact test apa
Novartis unveils new focused strategy, underpinned by eight
WebApr 14, 2024 · 20 years & counting! That’s how many years Advanced Accelerator Applications has pioneered in nuclear medicine imaging and therapy. As part of the Supply Chain and Customer Relations Team this role is critical in ensuring timely and safe delivery of medication to Canadian patients. Advanced Accelerator Applications, a Novartis … Web20 April 2024. Annual General Meeting. 27 April 2024. Ex-dividend date – 2024 final dividend, ordinary shares and ADRs. 28 April 2024. Record date – 2024 final dividend, ordinary shares and ADRs. 17 May 2024. Dividend currency and DRIP election deadline. 23 May 2024. WebOct 27, 2024 · Financial Calendar. Economic Calendar. Currency Converter. ProRealTime Trading. ... Novartis Investor Relations Q3 2024 Results Investor presentation October 27, 2024 Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be ... how to report findings